A female patient with Xp21 gene deletion syndrome |
Kim, Jungeun
(Department of Pediatrics, Gangnam Severance Children's Hospital, Yonsei University College of Medicine)
Lee, Hyunjoo (Department of Pediatrics, Gangnam Severance Children's Hospital, Yonsei University College of Medicine) Na, Ji-Hoon (Department of Pediatrics, Gangnam Severance Children's Hospital, Yonsei University College of Medicine) Lee, Young-Mock (Department of Pediatrics, Gangnam Severance Children's Hospital, Yonsei University College of Medicine) |
1 | Shaikh MG, Boyes L, Kingston H, Collins R, Besley GT, Padmakumar B, et al. Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenita. J Med Genet 2008;45:e1. DOI |
2 | Falsaperla R, Romeo G, Sorge A, Bianchini R, DiGiorgio A, Trigilia T, et al. Mental retardation and early onset of weakness in a girl with a dystrophinopathy and a large Xp21-23 deletion. J Child Neurol 2003;18:79-81. DOI |
3 | Wikiera B, Jakubiak A, Zimowski J, Noczynska A, Smigiel R. Complex glycerol kinase deficiency - X-linked contiguous gene syndrome involving congenital adrenal hypoplasia, glycerol kinase deficiency, muscular Duchenne dystrophy and intellectual disability (IL1RAPL gene deletion). Pediatr Endocrinol Diabetes Metab 2012;18:153-7. |
4 | Jamroz E, Paprocka J, Popowska E, Pytel J, Ciara E, Adamowicz M. Xp21.2 contiguous gene syndrome due to deletion involving glycerol kinase and Duchenne muscular dystrophy loci. Neurol India 2010;58:670-1. DOI |
5 | Fries MH, Lebo RV, Schonberg SA, Golabi M, Seltzer WK, Gitelman SE, et al. Mental retardation locus in Xp21 chromosome microdeletion. Am J Med Genet 1993;46:363-8. DOI |
6 | Heide S, Afenjar A, Edery P, Sanlaville D, Keren B, Rouen A, et al. Xp21 deletion in female patients with intellectual disability: two new cases and a review of the literature. Eur J Med Genet 2015;58:341-5. DOI |
7 | Wilson K, Faelan C, Patterson-Kane JC, Rudmann DG, Moore SA, Frank D, et al. Duchenne and Becker muscular dystrophies: a review of animal models, clinical end points, and biomarker quantification. Toxicol Pathol 2017;45:961-76. DOI |
8 | Sevim U, Fatma D, Ihsan E, Gulay C, Nevin B. A neonate with contiguous deletion syndrome in XP21. J Pediatr Endocrinol Metab 2011;24:1095-8. |
9 | Joo MA, Choi MS, Kim EY, Park SK. A case of Xp21 contiguous gene deletion syndrome. Med J Chosun Univ 2013;38:92-5. |